SEC Form 4/A · accession 0000886163-15-000034
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Charles S Berkman
Officer — VP, Gen. Counsel & Secretary
Period of report
Dec 31, 2014
Accepted (ET)
Mar 18, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 31, 2014 | J | 126 | $45.2285 | A | 27,433 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).
- F2The Amount of Securities Beneficially Owned is reflected as of the original filing date.